Yaping Xu

1.6k total citations
63 papers, 1.1k citations indexed

About

Yaping Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yaping Xu has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 20 papers in Surgery. Recurrent topics in Yaping Xu's work include Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Research Studies (12 papers). Yaping Xu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Research Studies (12 papers). Yaping Xu collaborates with scholars based in China, United States and India. Yaping Xu's co-authors include Xinmin Yu, Shenglin Ma, Qinghua Deng, Xiaojiang Sun, Yue Zeng, Deqing Wu, Xingpeng Wang, Weimin Mao, Qixun Chen and Weimin Mao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Yaping Xu

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaping Xu China 19 495 411 317 233 174 63 1.1k
Jingao Li China 18 338 0.7× 297 0.7× 329 1.0× 196 0.8× 187 1.1× 85 1.1k
Sabrina Rossetti Italy 17 404 0.8× 256 0.6× 393 1.2× 244 1.0× 189 1.1× 63 972
Chadrick E. Denlinger United States 23 638 1.3× 447 1.1× 677 2.1× 293 1.3× 210 1.2× 58 1.6k
Koichi Kurishima Japan 19 889 1.8× 550 1.3× 313 1.0× 140 0.6× 138 0.8× 92 1.4k
Dolores Gallardo‐Rincón Mexico 18 275 0.6× 524 1.3× 494 1.6× 165 0.7× 219 1.3× 49 1.3k
Nobuhiro Kanaji Japan 18 530 1.1× 295 0.7× 359 1.1× 131 0.6× 269 1.5× 80 1.2k
Adam Lam United States 15 901 1.8× 217 0.5× 248 0.8× 367 1.6× 80 0.5× 35 1.4k
Enzo Maria Ruggeri Italy 22 535 1.1× 681 1.7× 274 0.9× 354 1.5× 279 1.6× 103 1.4k
Yuichiro Takeda Japan 20 629 1.3× 780 1.9× 387 1.2× 351 1.5× 118 0.7× 123 1.6k

Countries citing papers authored by Yaping Xu

Since Specialization
Citations

This map shows the geographic impact of Yaping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Xu more than expected).

Fields of papers citing papers by Yaping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Xu. The network helps show where Yaping Xu may publish in the future.

Co-authorship network of co-authors of Yaping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaping Xu. A scholar is included among the top collaborators of Yaping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaping Xu. Yaping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yan, Yujie, Leilei Wu, Xuefei Li, Lan Zhao, & Yaping Xu. (2023). Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury. Frontiers in Oncology. 13. 966060–966060. 12 indexed citations
3.
Wang, Huijie, Lin Zhu, Lina Wang, et al.. (2022). Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease. Respiratory Research. 23(1). 27–27. 6 indexed citations
4.
Liu, Jie, Xiao Yang, Liang Zhang, et al.. (2020). Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma. Experimental Cell Research. 394(2). 112134–112134. 9 indexed citations
5.
Li, Qian, Yu Liu, Bin Su, et al.. (2020). The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer. Translational Lung Cancer Research. 9(3). 713–721. 8 indexed citations
6.
Shi, Yan, Tao Wang, Yong Zhou, et al.. (2019). MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease. Mucosal Immunology. 13(2). 303–312. 29 indexed citations
7.
Xu, Yaping, Wenbin Ji, Chao Zhou, et al.. (2019). OA06.07 Discrimination of Lung Invasive Adenocarcinoma with Micropapillary Pattern Based on CT Radiomics. Journal of Thoracic Oncology. 14(10). S222–S222. 1 indexed citations
8.
Nichol, Michael B., Yaping Xu, Judith Baker, et al.. (2017). Health-Related Quality of Life and Health Insurance Coverage Among Persons with Hemophilia A Inhibitors. Blood. 130. 4736–4736. 1 indexed citations
9.
Peng, Rui, Xiaoyong Huang, Chi Zhang, et al.. (2017). Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance. OncoTargets and Therapy. Volume 10. 5863–5872. 18 indexed citations
10.
Mao, Weimin, Lei Tao, Xiaoling Xu, Wei Chen, & Yaping Xu. (2016). Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer. OncoTargets and Therapy. 9. 921–921. 7 indexed citations
11.
Cheng, Yin, Hongyi Liu, Yaping Xu, et al.. (2016). Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma. Cellular Physiology and Biochemistry. 39(5). 1795–1803. 25 indexed citations
12.
Xu, Yaping, Deqing Wu, Yue Zeng, & Xingpeng Wang. (2012). Pancreatic Exocrine Function and Morphology Following an Episode of Acute Pancreatitis. Pancreas. 41(6). 922–927. 16 indexed citations
13.
Wang, Fan, Lei He, Weiqi Dai, et al.. (2012). Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo. PLoS ONE. 7(12). e50638–e50638. 101 indexed citations
14.
Xu, Yaping, Xinmin Yu, Qixun Chen, & Weimin Mao. (2012). Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?. World Journal of Surgical Oncology. 10(1). 173–173. 59 indexed citations
15.
Wu, Deqing, Yaping Xu, Yue Zeng, & Xingpeng Wang. (2011). Endocrine Pancreatic Function Changes After Acute Pancreatitis. Pancreas. 40(7). 1006–1011. 48 indexed citations
16.
Xu, Yaping, Yiping Zhang, & Shenglin Ma. (2011). EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer. Lung Cancer. 73(3). 249–255. 19 indexed citations
17.
18.
Wang, Yuetao, et al.. (2009). Primary Hepatic Tuberculoma Appears Similar to Hepatic Malignancy on F-18 FDG PET/CT. Clinical Nuclear Medicine. 34(8). 528–529. 16 indexed citations
19.
Xu, Yaping, et al.. (2007). P3-206: Concomitant treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib. Journal of Thoracic Oncology. 2(8). S768–S768. 1 indexed citations
20.
Yang, Hong, Wenjian Zhang, Lian‐Qiu Wu, et al.. (2005). [Protection of liver sinusoidal endothelial cells from hypoxia-reoxygenation induced apoptosis by alpha-1 antitrypsin in vitro].. PubMed. 85(2). 106–10. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026